News

Learn more about our company, latest developments in clinical diagnostics, and scientific breaktroughs in the rare disease field.

Stay on top, subscribe to our newsletter and follow us on social media.

  1. News

News


ROSTOCK, GERMANY, May 9, 2018 – CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment...


Rostock, Germany, May 4, 2018 – CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients,...


ROSTOCK, GERMANY, May 2, 2018 – CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients,...


ROSTOCK, GERMANY, April 27, 2018 – CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients,...


ROSTOCK, GERMANY, April 10, 2018 – CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients,...


Dr. Anton Mamin has recently started his new position being responsible for strategic guidance to clinical trial growth...


CENTOGENE´s Chief Financial Officer, Richard Stoffelen, is scheduled to present at the upcoming Cowen and Company 38th...


There are more than 7,000 rare diseases where about 80% are hereditary. About 30 million Americans are living with a...


We mark Rare Disease Day 2018 with continued commitment to reduce time to diagnosis of rare diseases.

CENTOGENE has...


Prof. Arndt Rolfs has joined newly formed “The Global Commission to End the Diagnostic Odyssey for Children”, a...